Evommune, Inc.: documents
20 reports and filings since Oct 9, 2025, each linked to the copy the company filed with the regulator.
Annual reports#
1 on file.
- Mar 5, 202610-KAnnual report, period to 31 December 2025all files
Quarterly reports#
4 on file.
- Nov 12, 202610-QQuarterly report, period to 30 September 2026all files
- Aug 6, 202610-QQuarterly report, period to 30 June 2026all files
- May 7, 202610-QQuarterly report, period to 31 March 2026all files
- Dec 11, 202510-QQuarterly report, period to 30 September 2025all files
Results announcements#
5 on file.
- Nov 12, 20268-KResults announced (item 2.02): the press release is an exhibitall files
- Aug 6, 20268-KResults announced (item 2.02): the press release is an exhibitall files
- May 7, 20268-KResults announced (item 2.02): the press release is an exhibitall files
- Mar 5, 20268-KResults announced (item 2.02): the press release is an exhibitall files
- Dec 11, 20258-KResults announced (item 2.02): the press release is an exhibitall files
Proxy statements#
1 on file.
- Apr 21, 2026DEF 14AProxy statement, period to 21 April 2026all files
Other current reports#
5 on file.
- Nov 17, 20268-KDirectors and officersall files
- Nov 4, 20268-KMaterial agreement; Unregistered share saleall files
- Jun 2, 20268-KShareholder voteall files
- Feb 13, 20268-KMaterial agreement; Unregistered share saleall files
- Nov 7, 20258-KBylaws or fiscal year changedall files
Registration statements and prospectuses#
4 on file.
- Apr 17, 2026S-1Registration statementall files
- Nov 6, 2025424B4Final prospectusall files
- Oct 17, 2025S-1/ARegistration statement, amendedall files
- Oct 9, 2025S-1Registration statementall files